Advanced search
Publication Cover
Journal of Immunotoxicology Volume 12, 2015 - Issue 3
Submit an article Journal homepage
691
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation

Takefumi InadaDepartment of Anesthesiology, Kansai Medical University, Osaka, JapanCorrespondence[email protected]
,
Kiichi HirotaDepartment of Anesthesiology, Kansai Medical University, Osaka, Japan
&
Koh ShinguDepartment of Anesthesiology, Kansai Medical University, Osaka, Japan
Pages 261-265 | Received 27 Mar 2014, Accepted 23 Jun 2014, Published online: 21 Jul 2014

References

  • Bradley, P. P., Priebat, D. A., Christensen, R. D., and Rothstein, G. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206–209
  • Haribabu, B., Verghese, M. W., Steeber, D. A., et al. 2000. Targeted disruption of the leukotriene B4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J. Exp. Med. 192:433–438
  • Henderson W. R Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684–697
  • Inada, T., Asai, T., Yamada, M., and Shingu, K. 2004. Propofol and midazolam inhibit gastric emptying and gastrointestinal transit in mice. Anesth. Analg. 99:1102–1106
  • Inada, T., Kubo, K., and Shingu, K. 2010. Promotion of IFNγ production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E2 production using intravenous anesthetic propofol. Int. Immunopharmacol. 10:1200–1208
  • Inada, T., Kubo, K., Ueshima, H., and Shingu, K. 2011. Intravenous anesthetic propofol suppresses prostaglandin E2 production in murine dendritic cells. J. Immunotoxicol. 8:359–366
  • Inada, T., Ueshima, H., and Shingu, K. 2013. Intravenous anesthetic propofol suppresses leukotriene production in murine dendritic cells. J. Immunotoxicol. 10:162–169
  • Inoue, H., Mori, T., and Koshihara, Y. 1988. Sulfidopeptide-leukotrienes are major mediators of arachidonic acid-induced mouse ear edema. Prostaglandins. 36:731–739
  • Kambara, T., Inada, T., Kubo, K., and Shingu, K. 2009. Propofol suppresses prostaglandin E2 production in human peripheral monocytes. Immunopharmacol. Immunotoxicol. 31:117–126
  • Kubo, K., Inada, T., and Shingu, K. 2011. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease. Brain. Res. 1387:125–133
  • Manev, H., Chen, H., Dzitoyeva, S., and Manev, R. 2011. Cyclooxygenases and 5-lipoxygenase in Alzheimer s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 35:315–319
  • Morimoto, K., Shirata, N., Taketomi, Y., et al. 2014. Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J. Immunol. 192:1130–1137
  • Rao, N. L., Dunford, P. J., Xue, X., et al. 2007. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J. Pharmacol. Exp. Ther. 21:1154–1160
  • Teeling, J. L., Cunningham, C., Newman, T. A., and Perry, V. H. 2010. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav. Immun. 24:409–419
  • Teismann P, and Ferger, B. 2001. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse 39:167–174
  • Vanlersberghe, C., and Camu, F. 2008. Propofol. Handbook Exp. Pharmacol. 182:227–252
  • Vasileiou, I., Xanthos, T., Koudouna, E., et al. 2009. Propofol: A review of its non-anesthetic effects. Eur. J. Pharmacol. 605:1–8
  • Young, J. M., Spires, D. A., Bedord, C. J., et al. 1984. The mouse ear inflammatory response to topical arachidonic acid. J. Invest. Dermatol. 82:367–371

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.